Abstract P5-15-01: Evaluation of sustained antiemetic efficacy over repeated cycles of anthracycline-cyclophosphamide (AC)-based chemotherapy: A phase 3 study of NEPA, a fixed-dose combination of netupitant and palonosetron for prevention of chemotherapy-induced nausea and

2015 ◽  
Author(s):  
Matti Aapro ◽  
Hope Rugo ◽  
Giada Rizzi
Keyword(s):  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Phase 3 ◽  
Antiemetic Efficacy ◽  
Dose Combination

Tu2038 All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

2014 ◽  
Vol 146 (5) ◽  
pp. S-903 ◽  
Author(s):  
Ira M. Jacobson ◽  
Patrick Marcellin ◽  
Alessandra Mangia ◽  
Paul Y. Kwo ◽  
Graham Foster ◽  
...  
Keyword(s):  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Genotype 1 ◽  
Phase 3 ◽  
Treatment Naïve ◽  
Dose Combination

Fixed-dose combination of nebivolol and valsartan in patients with stage 1 or 2 hypertension: ABPM substudy of a phase 3 randomized trial

2014 ◽  
Vol 8 (4) ◽  
pp. e31
Author(s):  
Thomas D. Giles ◽  
George Bakris ◽  
Suzanne Oparil ◽  
Michael A. Weber ◽  
Wei Chen ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Phase 3 ◽  
Dose Combination ◽  
Stage 1
Sign in / Sign up

Export Citation Format

Share Document